Perceptive Advisors LLC P Lx Pharma Inc. Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$12.22 - $21.28 $702,148 - $1.22 Million	-57,459 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.0 - $15.94 $1.48 Million - $2.63 Million	-164,721 Reduced 74.14%	57,459 $793,000
Q1 2021 May 17, 2021	BUY	$5.24 - $10.14 $1.16 Million - $2.25 Million	222,180 New	222,180 $2.01 Million

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.